Project Number Leigh/Jul15/971-797 Agency/Funding Organization MND Association Funding Year 2015 View Full Project Details for Efficacy and safety of low-dose IL-2 (Id-IL-2) as a Treg enhancer for controlling neuro-inflammation in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients (MIROCALS) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) Researcher and Organization Principal Investigator Leigh, Nigel Principal Investigator First Name Nigel Principal Investigator Last Name Leigh Awardee Organization University of Sussex Contact PI Country United Kingdom Project Detail FY Overall Cost $389,025 Funding Organization Agency/Funding Organization MND Association Funding Organization Country United Kingdom
